BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1347305)

  • 1. CD8+ T cells can be primed in vitro to produce IL-4.
    Seder RA; Boulay JL; Finkelman F; Barbier S; Ben-Sasson SZ; Le Gros G; Paul WE
    J Immunol; 1992 Mar; 148(6):1652-6. PubMed ID: 1347305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1.
    Chen H; Paul WE
    J Immunol; 1997 Sep; 159(5):2240-9. PubMed ID: 9278312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro maturation of neonatal human CD8 T lymphocytes into IL-4- and IL-5-producing cells.
    Byun DG; Demeure CE; Yang LP; Shu U; Ishihara H; Vezzio N; Gately MK; Delespesse G
    J Immunol; 1994 Dec; 153(11):4862-71. PubMed ID: 7963550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli.
    Tanaka T; Ben-Sasson SZ; Paul WE
    J Immunol; 1991 Jun; 146(11):3831-9. PubMed ID: 1827817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsets of activated CD4 T lymphocytes refractory for secretion of IL-2 are distinguished by expression of Ly-6A/E in BALB/c mice.
    Codias EK; Malek TR
    J Immunol; 1993 Dec; 151(11):5918-29. PubMed ID: 7902374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
    Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5.
    Taguchi T; Aicher WK; Fujihashi K; Yamamoto M; McGhee JR; Bluestone JA; Kiyono H
    J Immunol; 1991 Dec; 147(11):3736-44. PubMed ID: 1682383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production.
    Ben-Sasson SZ; Le Gros G; Conrad DH; Finkelman FD; Paul WE
    J Immunol; 1990 Aug; 145(4):1127-36. PubMed ID: 2143207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR-stimulated naive human CD4+ 45RO- T cells develop into effector cells that secrete IL-13, IL-5, and IFN-gamma, but no IL-4, and help efficient IgE production by B cells.
    Brinkmann V; Kristofic C
    J Immunol; 1995 Apr; 154(7):3078-87. PubMed ID: 7897199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of interleukin 4-producing T cells as a result of polyclonal priming. Use of a single-cell assay to detect interleukin 4-producing cells.
    Seder RA; Le Gros G; Ben-Sasson SZ; Urban J; Finkelman FD; Paul WE
    Eur J Immunol; 1991 May; 21(5):1241-7. PubMed ID: 1828031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5.
    Katamura K; Shintaku N; Yamauchi Y; Fukui T; Ohshima Y; Mayumi M; Furusho K
    J Immunol; 1995 Nov; 155(10):4604-12. PubMed ID: 7594459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.
    Sjöstedt A; Eriksson M; Sandström G; Tärnvik A
    Immunology; 1992 Aug; 76(4):584-92. PubMed ID: 1356911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental regulation of IL-4, IL-2, and IFN-gamma production by murine peripheral T lymphocytes.
    Adkins B; Ghanei A; Hamilton K
    J Immunol; 1993 Dec; 151(12):6617-26. PubMed ID: 7903095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine- and Ig-producing T cells in mucosal effector tissues: analysis of IL-5- and IFN-gamma-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues.
    Mega J; McGhee JR; Kiyono H
    J Immunol; 1992 Apr; 148(7):2030-9. PubMed ID: 1545116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.